1. Home
  2. YEXT vs CABA Comparison

YEXT vs CABA Comparison

Compare YEXT & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$3.83

Market Cap

397.0M

Sector

Technology

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.93

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
CABA
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.0M
319.6M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
YEXT
CABA
Price
$3.83
$2.93
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$7.50
$14.50
AVG Volume (30 Days)
1.3M
3.5M
Earning Date
06-02-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
131.82
10.26
EPS
0.02
N/A
Revenue
$170,201,000.00
N/A
Revenue This Year
$3.95
N/A
Revenue Next Year
$2.46
N/A
P/E Ratio
$198.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.27
$1.26
52 Week High
$9.20
$4.23

Technical Indicators

Market Signals
Indicator
YEXT
CABA
Relative Strength Index (RSI) 46.00 37.44
Support Level $3.66 $2.11
Resistance Level $4.14 $3.48
Average True Range (ATR) 0.24 0.26
MACD -0.00 -0.07
Stochastic Oscillator 40.15 13.36

Price Performance

Historical Comparison
YEXT
CABA

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: